Kurt Von Emster is Director at CRISPR Therapeutics AG (CRSP). They have made 51 open-market trades across 6 companies since 2006, most recently 2024-03-22.
CIK 0001252524
6 open-market purchases totalling $14.0M since 2009, against 45 sales. Across 5 scored buys the stock is up 28.9% at ninety days, and 24.9 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 80% | 60% | 80% |
| Avg Move | +16.4% | +16.1% | +28.9% |
| Alpha | +14.4% | +14.1% | +24.9% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CBAY | SELL · 10b5-1 | 2023-09-29 | 2023-09-29 | $15.68 | $499K | -8.9% | +10.7% | +61.9% |
| JSPR | SELL | 2023-04-13 | 2023-04-14 | $1.49 | $14K | -15.0% | +11.4% | +1.4% |
| VERA | BUY | 2021-05-17 | 2021-05-18 | $11.05 | $8.9M | +37.2% | +22.7% | +35.2% |
| PCVX | BUY | 2020-06-16 | 2020-06-18 | $16.00 | $200K | -5.4% | -7.2% | +44.8% |
| CRSP | SELL | 2018-12-18 | 2019-01-18 | $29.70 | $3.7M | -4.5% | -4.6% | +6.8% |
| CRSP | SELL | 2018-12-17 | 2018-12-19 | $29.97 | $2.3M | +4.6% | +30.0% | +30.4% |
| CBAY | SELL | 2018-12-17 | 2018-12-19 | $7.89 | $2.2M | +12.8% | +22.0% | +81.7% |
| CRSP | SELL | 2018-06-05 | 2018-06-07 | $12.51 | $12K | -6.4% | -4.7% | -19.4% |
| CBAY | SELL | 2018-06-05 | 2018-06-11 | $12.51 | $12K | +12.1% | +15.8% | +5.2% |
| CRSP | SELL | 2018-05-11 | 2018-05-15 | $54.41 | $70.2M | +19.2% | +0.7% | -19.8% |
| CBAY | SELL | 2018-03-05 | 2018-03-07 | $15.51 | $414K | -8.0% | -24.5% | -14.9% |
| CBAY | SELL | 2018-02-15 | 2018-02-20 | $14.49 | $2.0M | +1.5% | -14.6% | -16.4% |
| CBAY | SELL | 2018-02-14 | 2018-02-16 | $13.69 | $4.5M | -4.7% | -9.9% | -16.4% |
| CBAY | SELL | 2018-02-13 | 2018-02-15 | $15.41 | $4.2M | +0.3% | -8.9% | -18.5% |
| CBAY | SELL | 2018-02-07 | 2018-02-09 | $12.35 | $1.0M | +23.6% | +18.6% | -6.9% |
| CBAY | SELL | 2018-02-05 | 2018-02-07 | $12.14 | $457K | +19.0% | +19.1% | -2.3% |
| CBAY | SELL | 2018-02-01 | 2018-02-05 | $12.15 | $2.2M | +30.4% | +28.2% | +9.0% |
| CBAY | SELL | 2018-01-30 | 2018-02-01 | $12.22 | $2.2M | +12.3% | +24.4% | +1.3% |
| CBAY | SELL | 2018-01-25 | 2018-01-26 | $12.18 | $961K | +7.8% | +26.0% | +2.0% |
| CBAY | SELL | 2018-01-22 | 2018-01-24 | $10.40 | $2.9M | -4.8% | +21.6% | -0.1% |
| CBAY | SELL | 2018-01-18 | 2018-01-22 | $10.24 | $1.6M | +15.6% | +37.4% | +17.7% |
| CRSP | BUY | 2018-01-05 | 2018-01-11 | $22.75 | $3.0M | +27.1% | +26.8% | +69.0% |
| CRSP | SELL | 2018-01-05 | 2018-01-09 | $26.96 | $5.0M | +32.6% | +51.8% | +76.2% |
| CBAY | SELL · 10b5-1 | 2018-01-05 | 2018-01-09 | $10.21 | $44K | +13.2% | +30.0% | +24.4% |
| CRSP | SELL | 2018-01-02 | 2018-01-04 | $26.76 | $2.0M | +20.2% | +51.1% | +87.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total |
| $260.7M |
Shares reported on the most recent Form 4, priced at the 2023-09-29 close. 2 holdings could not be priced and are excluded from the total.